Home
About Us
Core Team
Development History
Corporate Culture
S&T
Research Areas
Technology Platforms
Research and Development
Marketed Products
R&D Products
R&D Pipeline
Academic Progress
Blog
Company News
Media Reports
Join Us
Post-Doctoral Center
Contact Us
[Decade in the Making] The 10th BioCon International Biopharmaceutical Exhibition Kicks Off Today, Embracing the New Wave of Biopharma
View details
→
[Case Study] Issue 251: Advanced Pancreatic Cancer Patient Over 80 Successfully Managed After Second-Line Treatment with Nivolumab
[Shengsheng Case] Issue 250: A Case of Advanced Esophageal Cancer Treated with Nivolumab Combined with Radiotherapy
June 2023
BioCon Exclusive Interview | Professor Bai Xianhong, Chairman of Biotech Pharma: Deepen Global Collaboration and Join Hands to Conquer "Cancer"!
Today, Biotech Pharma's "Nimotuzumab" received approval in China for the treatment of pancreatic cancer.